Hypothyroidism/subclinical hypothyroidism and metabolic dysfunction-associated steatotic liver disease: advances in mechanism and treatment

Hypothyroidism/subclinical hypothyroidism and metabolic dysfunction-associated steatotic liver disease: advances in mechanism and treatment

Abstract Hypothyroidism is a risk factor for metabolic dysfunction-associated steatotic liver disease (MASLD) but it is not clear whether subclinical hypothyroidism (SCH) increases the risk of MASLD and whether SCH patients with MASLD require treatment. In this study, we reviewed articles published...

Full description

Bibliographic Details
Main Authors: Sicheng Pu, Binbin Zhao, Yuxuan Jiang, Xuejiao Cui
Format: Article
Language:English
Published: BMC 2025-02-01
Series:Lipids in Health and Disease
Subjects:
Hypothyroidism
Subclinical hypothyroidism
Non-alcoholic fatty liver disease
Metabolic dysfunction-associated steatotic liver disease
Molecular roles
Thyroid-related medication
Online Access:https://doi.org/10.1186/s12944-025-02474-0

Internet

https://doi.org/10.1186/s12944-025-02474-0

Similar Items